Long non-coding RNA MDC1-AS inhibits human gastric cancer cell proliferation and metastasis through an MDC1-dependent mechanism

Gastric cancer is the third leading cause of cancer-associated mortality worldwide and is one of the most common malignancies in China. However, the molecular mechanisms underlying the tumorigenesis of gastric cancer remain largely unclear. Long non-coding (Lnc)RNAs have been demonstrated to serve significant roles in the tumorigenesis of various types of cancer. The present study aimed to explore the role of the LncRNA mediator of DNA damage checkpoint protein 1-antisense RNA (MDC1-AS), the antisense transcript of MDC1, in human gastric cancer. The results revealed that the expression of MDC1-AS in human gastric cancer was significantly suppressed in vivo and in vitro. In addition, overexpression of MDC1-AS in the poorly differentiated gastric cancer cell line MKN28 significantly inhibited cell proliferation and metastasis, while the knockdown of MDC1-AS in well-differentiated MKN45 gastric cancer cells significantly increased proliferation and metastasis. The knockdown of MDC1 relieved the inhibitory effect of MDC1-AS on MKN28 cell proliferation and metastasis, while the overexpression of MDC1 attenuated the stimulatory effect of MDC1-AS knockdown in MKN45 cells. Thus, the present study demonstrated that MDC1-AS had an inhibitory on gastric tumorigenesis through an MDC1-dependent mechanism. This indicates that MDC1-AS is a potential novel therapeutic target for the diagnosis and treatment of human gastric cancer in the clinic.

[1]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[2]  Y. Shao,et al.  LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer , 2016, Oncotarget.

[3]  Stephen J. Elledge,et al.  MDC1 is a mediator of the mammalian DNA damage checkpoint , 2003, Nature.

[4]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[5]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[6]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[7]  S. Nagini,et al.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. , 2012, World journal of gastrointestinal oncology.

[8]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[9]  A. Fatica,et al.  Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.

[10]  J. Rinn,et al.  Non-coding RNAs as regulators of embryogenesis , 2011, Nature Reviews Genetics.

[11]  J. Parsonnet,et al.  Role of Bacteria in Oncogenesis , 2010, Clinical Microbiology Reviews.

[12]  D. Cunningham,et al.  Capecitabine and oxaliplatin for advanced esophagogastric cancer. , 2010, The New England journal of medicine.

[13]  K. Morris,et al.  Long antisense non-coding RNAs and their role in transcription and oncogenesis , 2010, Cell cycle.

[14]  S. Knapp,et al.  BET inhibition as a new strategy for the treatment of gastric cancer , 2016, Oncotarget.

[15]  R. Ruddon.  Introduction to the molecular biology of cancer: translation to the clinic. , 2010, Progress in molecular biology and translational science.

[16]  Rui Li,et al.  Understanding the Functions of Long Non-Coding RNAs through Their Higher-Order Structures , 2016, International journal of molecular sciences.

[17]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[18]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[19]  Jie Zhu,et al.  MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  Xiang Du,et al.  Circulating long non-coding RNAs in cancer: current status and future perspectives , 2016, Molecular Cancer.

[21]  Ming Sun,et al.  Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression , 2016, Oncotarget.

[22]  A. Nakagawara,et al.  NFBD1/MDC1 Associates with p53 and Regulates Its Function at the Crossroad between Cell Survival and Death in Response to DNA Damage* , 2007, Journal of Biological Chemistry.

[23]  C. Qin,et al.  A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer , 2014, Oncotarget.

[24]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.